MedTrace Logo

Outcome of MC3 Ring Annuloplasty for Functional Tricuspid Regurgitation

NCT04078867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2019-09-06

No results posted yet for this study

Summary

This study includes 105 patients who underwent repair for ≥ moderate tricuspid regurgitation (TR) during mitral valve replacement for rheumatic valve disease. Between January 2016 and December 2018, a group of 23 patients underwent ring annuloplasty with Edward MC3 rings were compared to another group of 82 patients underwent standard suture (DeVega) repair. The primary outcome was residual TR (≥ moderate TR).

Conditions

  • Functional Tricuspid Regurgitation

Interventions

PROCEDURE

tricuspid valve repair

Tricuspid valve repair during mitral valve replacement for rheumatic heart disease using suture (DeVega) repair or ring annuloplasty

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Yasser A Kamal, MD · Minia University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04078867 on ClinicalTrials.gov